Vitaspring Biomedical (VSBC) EBIT Margin (2017 - 2022)
Vitaspring Biomedical (VSBC) recorded EBIT Margin of 23.03% in fiscal Q1 2023 (quarter ended Apr 30, 2022), down 10.58 percentage points from 33.61% a year earlier and down 17.66 percentage points from the prior quarter.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) EBIT Margin (2017 - 2022) Analysis & Trends
For FY2022 (ended Jan 31, 2022), Vitaspring Biomedical reported EBIT Margin of 20.07%, up 191.46 percentage points from FY2021.
- Annual EBIT Margin has a four-year change of +59.34 percentage points (FY2018 to FY2022).
- Across earlier fiscal years, EBIT Margin came in at -171.39% in FY2021 (-217.09 pp), 45.70% in FY2020 (+176.06 pp), -130.36% in FY2019 (-91.09 pp) and -39.27% in FY2018.
- Quarterly EBIT Margin has ranged from -17402.67% in fiscal Q3 2019 to 2631.75% in fiscal Q4 2019 over the past five years.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 720.36 percentage points in fiscal Q4 2019, against a drop of 17396.48 percentage points in fiscal Q3 2019 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 40.68% (Q4 2022), 68.73% (Q3 2022) and 18.04% (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Vitaspring Biomedical | 4.14 Mn | 4.12 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2022 | 23.03% |
| Jan 31, 2022 | 40.68% |
| Oct 31, 2021 | 68.73% |
| Jul 31, 2021 | 18.04% |
| Apr 30, 2021 | 33.61% |
| Jan 31, 2021 | -139.29% |
| Jan 31, 2020 | 526.86% |
| Apr 30, 2019 | -117.95% |
| Jan 31, 2019 | -88.70% |
| Oct 31, 2018 | -17,402.67% |
| Jul 31, 2018 | -584.80% |
| Apr 30, 2018 | 39.99% |
| Jan 31, 2018 | -235.82% |
| Oct 31, 2017 | -6.18% |
| Jul 31, 2017 | -23.36% |
| Apr 30, 2017 | -17.97% |
API Access
Vitaspring Biomedical EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();